메뉴 건너뛰기




Volumn 86, Issue 19, 2016, Pages 1754-1761

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BIOLOGICAL MARKER; CHOLINE; FLUTEMETAMOL F 18; INOSITOL; N ACETYLASPARTIC ACID; TAU PROTEIN; AMYLOID PROTEIN; APOLIPOPROTEIN E4; ASPARTIC ACID; MAPT PROTEIN, HUMAN; N-ACETYLASPARTATE;

EID: 84978396743     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002672     Document Type: Article
Times cited : (69)

References (33)
  • 1
    • 0033852551 scopus 로고    scopus 로고
    • Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study
    • Kantarci K, Jack CR Jr, Xu YC, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 2000;55:210-217.
    • (2000) Neurology , vol.55 , pp. 210-217
    • Kantarci, K.1    Jack, C.R.2    Xu, Y.C.3
  • 2
    • 0033811153 scopus 로고    scopus 로고
    • Proton MR spectros-copy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD
    • Jessen F, Block W, Traber F, et al. Proton MR spectros-copy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 2000;55:684-688.
    • (2000) Neurology , vol.55 , pp. 684-688
    • Jessen, F.1    Block, W.2    Traber, F.3
  • 3
    • 0035964302 scopus 로고    scopus 로고
    • Brain metabolite concentration and dementia severity in Alzheimer's disease: A (1)H MRS study
    • Huang W, Alexander GE, Chang L, et al. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology 2001;57:626-632.
    • (2001) Neurology , vol.57 , pp. 626-632
    • Huang, W.1    Alexander, G.E.2    Chang, L.3
  • 4
    • 84914706377 scopus 로고    scopus 로고
    • Early Alzheimer's disease neuropathology detected by proton MR spectroscopy
    • Murray ME, Przybelski SA, Lesnick TG, et al. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy. J Neurosci 2014;34:16247-16255.
    • (2014) J Neurosci , vol.34 , pp. 16247-16255
    • Murray, M.E.1    Przybelski, S.A.2    Lesnick, T.G.3
  • 5
    • 0027194791 scopus 로고
    • Gene dose of apolipoprotein e type 4 allele and the risk of Alzheimer's disease in late onset families
    • Corder E, Saunders A, Strittmatter W, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921-923.
    • (1993) Science , vol.261 , pp. 921-923
    • Corder, E.1    Saunders, A.2    Strittmatter, W.3
  • 7
    • 32544435900 scopus 로고    scopus 로고
    • Association between CSF bio-markers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study
    • Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF bio-markers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006;5:228-234.
    • (2006) Lancet Neurol , vol.5 , pp. 228-234
    • Hansson, O.1    Zetterberg, H.2    Buchhave, P.3    Londos, E.4    Blennow, K.5    Minthon, L.6
  • 8
    • 0025863618 scopus 로고
    • Neuropathological stageing of Alzheimer-related changes
    • Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82: 239-259.
    • (1991) Acta Neuropathol , vol.82 , pp. 239-259
    • Braak, H.1    Braak, E.2
  • 9
    • 77954528232 scopus 로고    scopus 로고
    • Reduced cortical thickness in the posterior cingulate gyrus is char acteristic of both typical and atypical Alzheimer's disease
    • Lehmann M, Rohrer JD, Clarkson MJ, et al. Reduced cortical thickness in the posterior cingulate gyrus is char acteristic of both typical and atypical Alzheimer's disease. J Alzheimers Dis 2010;20:587-598.
    • (2010) J Alzheimers Dis , vol.20 , pp. 587-598
    • Lehmann, M.1    Rohrer, J.D.2    Clarkson, M.J.3
  • 10
    • 0030874251 scopus 로고    scopus 로고
    • Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
    • Minoshima S, Giordani B, Berent S, Frey K, Foster N, Kuhl D. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
    • (1997) Ann Neurol , vol.42 , pp. 85-94
    • Minoshima, S.1    Giordani, B.2    Berent, S.3    Frey, K.4    Foster, N.5    Kuhl, D.6
  • 11
    • 80055073182 scopus 로고    scopus 로고
    • Magnetic resonance spectroscopy, b-amyloid load, and cognition in a population-based sample of cognitively normal older adults
    • Kantarci KLV, Przybelski SA, Senjem ML, et al. Magnetic resonance spectroscopy, b-amyloid load, and cognition in a population-based sample of cognitively normal older adults. Neurology 2011;77:951-958.
    • (2011) Neurology , vol.77 , pp. 951-958
    • Klv, K.1    Przybelski, S.A.2    Senjem, M.L.3
  • 12
    • 84898625633 scopus 로고    scopus 로고
    • APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain
    • Gomar JJ, Gordon ML, Dickinson D, et al. APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain. Biol Psychiatry 2013;75: 686-692.
    • (2013) Biol Psychiatry , vol.75 , pp. 686-692
    • Gomar, J.J.1    Gordon, M.L.2    Dickinson, D.3
  • 13
    • 84895440282 scopus 로고    scopus 로고
    • Clinical proton MR spectroscopy in central nervous system disorders
    • Öz G, Alger JR, Barker PB, et al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014;270:658-679.
    • (2014) Radiology , vol.270 , pp. 658-679
    • Öz, G.1    Alger, J.R.2    Barker, P.B.3
  • 14
    • 0034959727 scopus 로고    scopus 로고
    • Automatic quantitation of localized in vivo 1H spectra with LCModel
    • Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001; 14:260-264.
    • (2001) NMR Biomed , vol.14 , pp. 260-264
    • Provencher, S.W.1
  • 15
    • 0035852992 scopus 로고    scopus 로고
    • Magnetic resonance spectros-copy in AD
    • Valenzuela M, Sachdev P. Magnetic resonance spectros-copy in AD. Neurology 2001;56:592-598.
    • (2001) Neurology , vol.56 , pp. 592-598
    • Valenzuela, M.1    Sachdev, P.2
  • 16
    • 7044260964 scopus 로고    scopus 로고
    • Advances in functional and structural MR image analysis and implementation as FSL
    • Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1): S208-S219.
    • (2004) Neuroimage , vol.23 , pp. S208-S219
    • Smith, S.M.1    Jenkinson, M.2    Woolrich, M.W.3
  • 17
    • 66149104129 scopus 로고    scopus 로고
    • Whole-body bio-distribution and radiation dosimetry of 18F-GE067: A ra-dioligand for in vivo brain amyloid imaging
    • Koole M, Lewis DM, Buckley C, et al. Whole-body bio-distribution and radiation dosimetry of 18F-GE067: a ra-dioligand for in vivo brain amyloid imaging. J Nucl Med 2009;50:818-822.
    • (2009) J Nucl Med , vol.50 , pp. 818-822
    • Koole, M.1    Lewis, D.M.2    Buckley, C.3
  • 18
    • 84881461022 scopus 로고    scopus 로고
    • Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data
    • Lundqvist R, Lilja J, Thomas BA, et al. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data. J Nucl Med 2013;54: 1472-1478.
    • (2013) J Nucl Med , vol.54 , pp. 1472-1478
    • Lundqvist, R.1    Lilja, J.2    Thomas, B.A.3
  • 19
    • 77949423619 scopus 로고    scopus 로고
    • Cere-brospinal fluid and plasma biomarkers in Alzheimer disease
    • Blennow K, Hampel H, Weiner M, Zetterberg H. Cere-brospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 2010;6:131-144.
    • (2010) Nat Rev Neurol , vol.6 , pp. 131-144
    • Blennow, K.1    Hampel, H.2    Weiner, M.3    Zetterberg, H.4
  • 20
    • 0027374233 scopus 로고
    • Detection of proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay
    • Vandermeeren M, Mercken M, Vanmechelen E, et al. Detection of proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem 1993;61: 1828-1834.
    • (1993) J Neurochem , vol.61 , pp. 1828-1834
    • Vandermeeren, M.1    Mercken, M.2    Vanmechelen, E.3
  • 21
    • 84937571101 scopus 로고    scopus 로고
    • Nonlinear association between cerebrospinal fluid and florbetapir f-18 b-amyloid measures across the spectrum of Alzheimer disease
    • Toledo JB, Bjerke M, Da X, et al. Nonlinear association between cerebrospinal fluid and florbetapir f-18 b-amyloid measures across the spectrum of Alzheimer disease. JAMA Neurol 2015;72:571-581.
    • (2015) JAMA Neurol , vol.72 , pp. 571-581
    • Toledo, J.B.1    Bjerke Da M, X.2
  • 22
    • 84890528022 scopus 로고    scopus 로고
    • Biomarker modeling of Alzheimer's disease
    • Jack CR Jr, Holtzman DM. Biomarker modeling of Alzheimer's disease. Neuron 2013;80:1347-1358.
    • (2013) Neuron , vol.80 , pp. 1347-1358
    • Jack, C.R.1    Holtzman, D.M.2
  • 23
    • 84943227798 scopus 로고    scopus 로고
    • Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
    • Palmqvist S, Zetterberg H, Mattsson N, et al. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease. Neurology 2015;85:1240-1249.
    • (2015) Neurology , vol.85 , pp. 1240-1249
    • Palmqvist, S.1    Zetterberg, H.2    Mattsson, N.3
  • 24
    • 84875465982 scopus 로고    scopus 로고
    • Proton MRS in mild cognitive impairment
    • Kantarci K. Proton MRS in mild cognitive impairment. J Magn Reson Imaging 2013;37:770-777.
    • (2013) J Magn Reson Imaging , vol.37 , pp. 770-777
    • Kantarci, K.1
  • 25
    • 84865529158 scopus 로고    scopus 로고
    • Clinical and biomarker changes in dominantly inherited Alzheimer's disease
    • Bateman R, Xiong C, Benzinger T, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367:795-804.
    • (2012) N Engl J Med , vol.367 , pp. 795-804
    • Bateman, R.1    Xiong, C.2    Benzinger, T.3
  • 26
    • 84855304100 scopus 로고    scopus 로고
    • Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia
    • Buchhave P, Minthon L, Zetterberg H, Wallin A, Blennow K, Hansson O. Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry 2012;69:98-106.
    • (2012) Arch Gen Psychiatry , vol.69 , pp. 98-106
    • Buchhave, P.1    Minthon, L.2    Zetterberg, H.3    Wallin, A.4    Blennow, K.5    Hansson, O.6
  • 27
    • 0032743882 scopus 로고    scopus 로고
    • High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: A 1H MRS study
    • Huang W, Alexander GE, Daly EM, et al. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. Am J Psychiatry 1999;156:1879-1886.
    • (1999) Am J Psychiatry , vol.156 , pp. 1879-1886
    • Huang, W.1    Alexander, G.E.2    Daly, E.M.3
  • 28
    • 33645894186 scopus 로고    scopus 로고
    • MRS shows abnormalities before symptoms in familial Alzheimer disease
    • Godbolt AK, Waldman AD, MacManus DG, et al. MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology 2006;66:718-722.
    • (2006) Neurology , vol.66 , pp. 718-722
    • Godbolt, A.K.1    Waldman, A.D.2    MacManus, D.G.3
  • 29
    • 84875250937 scopus 로고    scopus 로고
    • Amyloid b deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study
    • Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid b deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol 2013;12:357-367.
    • (2013) Lancet Neurol , vol.12 , pp. 357-367
    • Villemagne, V.L.1    Burnham, S.2    Bourgeat, P.3
  • 31
    • 84873722367 scopus 로고    scopus 로고
    • Apolipoprotein e and Alzheimer disease: Risk, mechanisms and therapy
    • Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 2013;9:106-118.
    • (2013) Nat Rev Neurol , vol.9 , pp. 106-118
    • Liu, C.-C.1    Kanekiyo, T.2    Xu, H.3    Bu, G.4
  • 32
    • 84907805707 scopus 로고    scopus 로고
    • Apolipoprotein e genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease
    • Lautner R, Palmqvist S, Mattsson N, et al. Apolipoprotein e genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. JAMA Psychiatry 2014;71:1183-1191.
    • (2014) JAMA Psychiatry , vol.71 , pp. 1183-1191
    • Lautner, R.1    Palmqvist, S.2    Mattsson, N.3
  • 33
    • 76849104065 scopus 로고    scopus 로고
    • Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly
    • Sheline YI, Raichle ME, Snyder AZ, et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry 2010;67:584-587.
    • (2010) Biol Psychiatry , vol.67 , pp. 584-587
    • Sheline, Y.I.1    Raichle, M.E.2    Snyder, A.Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.